mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.03 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.03 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.04 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.05 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.06 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |